Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$13,510,188
+$5,846,506 QoQ
Shares Held
53,196
+69.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#938
of 4,664 holders
Holding Since
Dec 2023
11 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Simplicity Wealth,LLC holds $64,075,335 across 13 Drug Manufacturers - General names. JNJ ranks #2 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
81,682 | $20,554,458 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
53,196 | $13,510,188 | |
| 3 | LLY |
ELI LILLY & Co
|
9,693 | $11,626,075 | |
| 4 | MRK |
Merck & Co., Inc.
|
53,267 | $6,844,809 | |
| 5 | AMGN |
Amgen Inc
|
10,539 | $3,816,382 | |
| 6 | PFE |
Pfizer Inc
|
109,120 | $2,627,609 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
10,730 | $1,355,628 | |
| 8 | NVS |
Novartis AG
|
5,984 | $937,812 |
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,510,188 | 53,196 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $7,663,682 | 31,352 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,296,246 | 30,424 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $5,690,354 | 30,689 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $8,530,323 | 55,845 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $4,727,600 | 28,507 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,497,395 | 10,354 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $4,449,195 | 27,454 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $19,001,823 | 130,007 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $20,498,734 | 129,583 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $726,646 | 4,636 | Shares | Sole | 2024-01-29 | |
| No filing history on record for this holder in this stock. | ||||||